LAS VEGAS (KTNV) – The Nevada Wake Research-Clinical Research Center is looking for 60 children eligible for a vaccine study.
The WR-CRCN hopes to begin trials for children ages 12-17 sometime this week.
The participants will be compensated.
The studies relate to the Novavax vaccine, which is 96% effective against COVID-19.
According to the American Academy of Pediatrics, children now account for a fifth of new COVID-19 cases in the United States.
Children made up 22% of new COVID-19 cases last week, while children made up only 3% of all cases a year ago.